Chemed (NYSE:CHE) Updates FY 2026 Earnings Guidance
by Teresa Graham · The Cerbat GemChemed (NYSE:CHE – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 24.000-24.75 for the period, compared to the consensus earnings per share estimate of 23.480. The company issued revenue guidance of -.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the stock. Oppenheimer lowered their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Zacks Research cut shares of Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Royal Bank Of Canada restated a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Finally, Weiss Ratings cut shares of Chemed from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, April 13th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $498.00.
View Our Latest Stock Report on CHE
Chemed Trading Up 2.8%
Shares of NYSE:CHE traded up $10.27 during trading on Thursday, hitting $383.42. 258,558 shares of the company’s stock were exchanged, compared to its average volume of 227,754. Chemed has a 1-year low of $365.20 and a 1-year high of $583.96. The firm has a 50-day moving average price of $405.82 and a two-hundred day moving average price of $426.70. The firm has a market cap of $5.60 billion, a P/E ratio of 20.87, a PEG ratio of 1.48 and a beta of 0.49.
Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The business had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. During the same quarter in the prior year, the firm earned $6.83 EPS. The firm’s quarterly revenue was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, research analysts predict that Chemed will post 21.92 EPS for the current year.
Chemed Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were issued a dividend of $0.60 per share. The ex-dividend date was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s payout ratio is currently 13.06%.
Insider Transactions at Chemed
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the transaction, the chief executive officer owned 93,719 shares in the company, valued at approximately $37,785,626.42. The trade was a 2.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 3.29% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. Los Angeles Capital Management LLC acquired a new position in Chemed during the fourth quarter valued at approximately $26,000. Global Retirement Partners LLC grew its holdings in Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after purchasing an additional 58 shares during the period. Geneos Wealth Management Inc. grew its holdings in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares during the period. Employees Retirement System of Texas acquired a new position in Chemed during the third quarter valued at approximately $64,000. Finally, Caitong International Asset Management Co. Ltd grew its holdings in Chemed by 5,333.3% during the third quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company’s stock valued at $73,000 after purchasing an additional 160 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.
About Chemed
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.